Blockade of NKG2D signaling prevents the development of murine CD4+ T cell-mediated colitis
Blockade of NKG2D signaling prevents the development of murine CD4+ T cell-mediated colitis
复制标题
DOI:
10.1152/ajpgi.00286.2007
复制
发表时间:
2008-01-01
影响因子:
4.5
通讯作者:
Watanabe, M.
中科院分区:
文献类型:
--
作者:
Ito, Y.;Kanai, T.;Watanabe, M.
It has been recently demonstrated that NKG2D is an activating costimulatory receptor on natural killer (NK) cells, natural killer T (NKT) cells, activated CD8(+) T cells, and gamma delta T cells, which respond to cellular stress, such as inflammation, transformation, and infection. Here we show that intestinal inflammation in colitic SCID mice induced by adoptive transfer of CD4(+) CD45RB(high) T cells is characterized by significant increase of CD4(+)NKG2D(+) T cells and constitutive expression of NKG2D ligands, such as H60, Mult-1, and Rae-1, by lamina propria CD11c(+) dendritic cells. Furthermore, treatment with nondepleting and neutralizing anti-NKG2D MAb after transfer of CD4(+)CD45RB(high) T cells into SCID mice significantly suppressed wasting disease with colitis, abrogated leukocyte infiltration, and reduced production of IFN-gamma by lamina propria CD4(+) T cells. These findings demonstrate that NKG2D signaling pathway is critically involved in CD4(+) T cell-mediated disease progression and suggest a new therapeutic target for inflammatory bowel diseases.